Final results of a phase II study of voreloxin in women with platinum-resistant ovarian cancer. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hirte, Holger
  • McGuire, WP
  • Edwards, RP
  • Husain, A
  • Hoskins, P
  • Michels, JE
  • Matulonis, U
  • Sexton, C
  • Fox, JA
  • Michelson, G

publication date

  • May 20, 2010